🇺🇸 FDA
Patent

US 7553840

4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

granted A61KA61K31/4152A61K31/506

Quick answer

US patent 7553840 (4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use) held by LEXICON PHARMACEUTICALS, INC. expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4152, A61K31/506, A61P, A61P1/00